Investor Relations

Stock Quote (NASDAQ: PODD)

- 1.17
Day High:
Day Low:
4:00 PM ET on Aug 20, 2014
Delayed ~20 min. By eSignal.
Stock price graph

Corporate Profile

Insulet Corporation is an innovative medical device company based in Bedford, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional pump technology...More ▼

View all »   RSSRecent Releases

Aug 15, 2014
Insulet Appoints Timothy J. Scannell to Board of Directors

Aug 7, 2014
Insulet Reports Second Quarter 2014 Results

View all »Events & Presentations

Aug 14, 2014
Insulet Corporation to Present at the Canaccord Genuity 34th Annual Growth Conference
Webcast Listen to webcast

Aug 7, 2014
Q2 2014 Insulet Corporation Earnings Conf Call
Webcast Listen to webcast